A woman with a nonhealing ulcer of the jaw - Gingival ulceration, inflammation, and acute osteomyelitis with actinomyces, all associated with necrosis of bone (bisphosphonate-related osteonecrosis of bone)

被引：31

作者：

Dodson, Thomas B. ^{[1
,6
]}

Raje, Noopur S. ^{[2
,7
]}

Caruso, Paul A. ^{[3
,5
,8
]}

Rosenberg, Andrew E. ^{[4
,9
]}

Smullin, Steven E.

Harris, Nancy Lee

机构：

[1] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Oncol, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA

[4] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[5] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA

[6] Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Cambridge, MA 02138 USA

[7] Harvard Univ, Sch Med, Dept Oncol, Cambridge, MA 02138 USA

[8] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA

[9] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 12期

关键词：

D O I：

10.1056/NEJMcpc0800341

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1283 / 1291

页数：9

共 44 条

[1] American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws [J].

不详 .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (03) :369-376

[2] Osteonecrosis: what does it mean? One condition partly caused by bisphosphonates - or another one, preferably treated with them? [J].

Aspenberg, Per .

ACTA ORTHOPAEDICA, 2006, 77 (05) :693-694

[3] Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].

Badros, A ;

Weikel, D ;

Salama, A ;

Goloubeva, O ;

Schneider, A ;

Rapoport, A ;

Fenton, R ;

Gahres, N ;

Sausville, E ;

Ord, R ;

Meiller, T .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952

[4] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].

Bamias, A ;

Kastritis, E ;

Bamia, C ;

Moulopoulos, LA ;

Melakopoulos, L ;

Bozas, G ;

Koutsoukou, V ;

Gika, D ;

Anagnostopoulos, A ;

Papadimitriou, C ;

Terpos, E ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587

[5]

Berenson J, 1996, BRIT J CLIN PRACT, P5

[6] American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma [J].

Berenson, JR ;

Hillner, BE ;

Kyle, RA ;

Anderson, K ;

Lipton, A ;

Yee, GC ;

Biermann, JS .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3719-3736

[7]

Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO

[8]

2-0

[9] Osteonecrosis of the jaw - Do biphosphonates pose a risk? [J].

Bilezikian, John P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2278-2281

[10] Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

← 1 2 3 4 5 →